← Eichor
Condition: Kidney Failure Chronic Therapy Hemodialysis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Kidney Failure Chronic Therapy Hemodialysis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins
Phase N/A · 1 location(s) · Xinhua Hospital, Shanghai Jiao Tong University School of Med · NCT07016841
The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp
NA · 1 location(s) · Zealand University Hospital · NCT04330729
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filte
Phase N/A · 2 location(s) · Fresenius Medical Care Deutschland GmbH · NCT05282732
Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis
NA · 1 location(s) · King Chulalongkorn Memorial Hospital · NCT06906835
Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients
Phase 3 · 2 location(s) · University Hospital, Tours · NCT05410275
Prophylactic Antibiotic Treatment in Hemodialysis
NA · 7 location(s) · Zealand University Hospital · NCT05248620
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Dise
Phase 3 · 2 location(s) · Biocad · NCT07119372
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Phase 1/Phase 2 · 5 location(s) · Oncorena AB · NCT05287945
Rheopheresis as Adjuvant Treatment of Calciphylaxis
NA · 29 location(s) · University Hospital, Lille · NCT04654000
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
NA · 1 location(s) · Yunfeng Xia · NCT07291154
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
NA · 1 location(s) · Fresenius Medical Care Deutschland GmbH · NCT06341452
The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion
NA · 5 location(s) · Scitech Produtos Medicos SA · NCT06096142
AI-Guided Relaxation for Hemodialysis Anxiety
NA · 2 location(s) · Alexandria University · NCT07522944
This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Ord
Phase N/A · 1 location(s) · Sohag University · NCT07144332
Exercise Therapy on Rheological Functions of Erythrocyte in Hemodialysis
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT06575634
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
NA · 1 location(s) · Peking University People's Hospital · NCT07111260
A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialy
NA · 1 location(s) · Mohammad Arian · NCT07361146
Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice'
NA · 1 location(s) · Duke-NUS Graduate Medical School · NCT07309367
Safety and Efficacy of Empagliflozin in Hemodialysis
Phase 2 · 2 location(s) · NYU Langone Health · NCT05786443
Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patien
NA · 1 location(s) · Saint Petersburg State University, Russia · NCT06671535
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.